Bliss GVS Pharma Ltd - 506197 - Statement Of Investor Complaints For The Quarter Ended March 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- Ms. Aditi BhattDesignation :- Company Secretary and Compliance Officer Bliss GVS Pharma Ltd - 506197 - Compliance Under Regulation 47 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015- Newspaper Advertisements - Declaration Of Postal Ballot Results
Pursuant to the provisions of Regulation 47(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the extract copies of newspaper advertisement clippings of declaration of result of Postal Ballot of the Company declared on April 13, 2019 published in 'The Free Press Journal' an English Daily and 'Navshkati' a Regional Daily, on April 17, 2019. Kindly take the same on record BLISS GVS PHARMA LTD. - 506197 - Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Bliss GVS Pharma Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here BLISS GVS PHARMA LTD. - 506197 - Declaration Of Result Of The Postal Ballot
Please find attached the Declaration of Result of the Postal BAllot process pursuant to provisions of Section 110 of the Companies Act, 2013 read with Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Bliss GVS Pharma Ltd - 506197 - Closure of Trading Window
With reference to the circulars issued by BSE vide Circular no. LIST/COMP/01/2019-20 and NSE vide Circular no. NSE/CML/2019/11 dated April 2, 2019 pertaining to clarification regarding trading restriction period. In complying with the aforesaid circulars and pursuant to SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018, we wish to inform you that, the Trading window for dealing in securities/shares of the Company will remain closed for all the Designated Persons and their immediate relatives of the Company with immediate effect (i.e. April 4, 2019) until 48 hours after the announcement of the financial results of the Company for the quarter and financial year ended March 31, 2019. Kindly take the above information on record. BLISS GVS PHARMA LTD. - 506197 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Registrar and Transfer Agent of Company M/s. Universal Capital Securities Private Limited has received request for issue of duplicate Share Certificates. Bliss GVS Pharma Ltd - 506197 - Copy Of Newspaper Advertisement Confirming Dispatch Of Postal Ballot Notice & Form
Pursuant to the provision of Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the copy of the newspaper advertisement confirming dispatch of Postal Ballot Notice dated February 25, 2019 alongwith postal ballot form published in 'The Free Press Journal' an English Daily and 'Navshkati' a Regional Daily, on March 14, 2019. BLISS GVS PHARMA LTD. - 506197 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Pursuant to Section 110 of the Companies Act, 2013 read with Rule 22 of the Companies (Management and Administration) Rules, 2014 and Regulation 30 Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI LODR'), please find enclosed herewith the Calendar of Events for the Postal Ballot process and a copy of the Notice of Postal Ballot dated February 25, 2019 alongwith the postal ballot form being sent to all the members of the Company by the permitted mode, seeking their approval to transact the special businesses. Bliss GVS Pharma Ltd - 506197 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Registrar and Transfer Agent of Company M/s. Universal Capital Securities Private Limited has received request for issue of duplicate Share Certificates. BLISS GVS PHARMA LTD. - 506197 - Outcome of Board Meeting
Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that Board Meeting of the Company was held today at the registered office of the Company. 1.The Nomination & Remuneration Committee and the Board approved the draft scheme of Employee Stock Option Plan-2019 and considered to include Mr. Gagan Sharma, Mr. Vishal Rao and Mr. Arjun Ashra, who are KMPs & professionals and also connected to promoters as part of said scheme of Employee Stock Option Plan. 2.The Board approved the increase of Foreign Portfolio Investors/Foreign Institutional Investors limits from 24% to 74% in the Company. 3.The Nomination & Remuneration Committee and the Board approved the re-appointment and continuation of term of Independent Director of Mr. S. R. Vaidya, who is reached as of 77 years. The meeting of the Board of Directors commenced at 11.00 a.m. and concluded at 5:15 p.m.